BROWSE

Related Researcher

Author's Photo

Ryu, Ja-Hyoung
Supramolecular NanoMaterials Lab (SUN)
Research Interests
  • Supramolecular assembly, synthetic peptide assembly, cancer drug delivery

ITEM VIEW & DOWNLOAD

Cancer-targeted nanomedicine: overcoming the barrier of protein corona

Cited 0 times inthomson ciCited 0 times inthomson ci
Title
Cancer-targeted nanomedicine: overcoming the barrier of protein corona
Author
Barui, Ayan KumarOh, Jun YongJana, BatakrishnaKim, ChaekyuRyu, Ja-Hyoung
Issue Date
2020-01
Publisher
Wiley Blackwell
Citation
ADVANCED THERAPEUTICS, v.3, no.1, pp.1900124
Abstract
Nanomedicines exploit the unusual physicochemical and biological properties of nanoparticles, including their nanoscopic size, high surface‐area‐to‐volume ratio, easy surface modification, and biocompatibility. Among various therapeutic and diagnostic applications of nanomedicines, cancer‐targeted drug delivery systems (DDS) have been found to be a promising area of research. Effective DDS rely on two major factors: slow and sustained release of chemotherapeutic drugs and their targeted delivery to tumor sites. Both the drug release and targeting ability of nanoparticles are greatly affected under in vivo conditions by the “protein corona,” a tightly packed layer of protein molecules, formed around nanoparticles upon contact with biological fluids. Owing to the adsorption of proteins onto the surface of nanoparticles, their identity is significantly altered, and they can readily be cleared from systemic circulation by the mononuclear phagocytic system. In this context, scientists have employed various strategies, including the use of different ligands, stealth polymers, and protein corona shields/pre‐coating with specific proteins to modulate protein corona formation and retain the targeting ability of nanoparticles. This review article focuses on the recent progress of these different strategies with a special emphasis on the protein corona shields/artificial protein corona approaches for the development of effective cancer targeting nanomedicines.
URI
https://scholarworks.unist.ac.kr/handle/201301/27783
URL
https://onlinelibrary.wiley.com/doi/full/10.1002/adtp.201900124
DOI
10.1002/adtp.201900124
ISSN
2366-3987
Appears in Collections:
CHM_Journal Papers
Files in This Item:
There are no files associated with this item.

find_unist can give you direct access to the published full text of this article. (UNISTARs only)

Show full item record

qrcode

  • mendeley

    citeulike

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

MENU